Abstract
We have discovered 3-(5-thien-3-ylpyridin-3-yl)-1H-indoles as potent inhibitors of KDR kinase activity. This communication details the evolution of this novel class from a potent screening lead of vastly different structure with an emphasis on structural modifications that retained activity and provided improvements in key physical properties. The synthesis and in-depth evaluation of these inhibitors are described.
MeSH terms
-
Administration, Oral
-
Angiogenesis Inhibitors / chemical synthesis*
-
Angiogenesis Inhibitors / pharmacokinetics
-
Angiogenesis Inhibitors / pharmacology
-
Animals
-
Biological Availability
-
Cell Line
-
Half-Life
-
Indoles / chemical synthesis*
-
Indoles / pharmacokinetics*
-
Indoles / pharmacology
-
Inhibitory Concentration 50
-
Rats
-
Structure-Activity Relationship
-
Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*
Substances
-
Angiogenesis Inhibitors
-
Indoles
-
Vascular Endothelial Growth Factor Receptor-2